BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29903421)

  • 41. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
    Roghmann MC; McCarter RJ; Brewrink J; Cross AS; Morris JG
    Clin Infect Dis; 1997 Nov; 25(5):1056-9. PubMed ID: 9402356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal Multicenter Analysis of Outcomes After Cessation of Control Measures for Vancomycin-Resistant Enterococci.
    Lemieux C; Gardam M; Evans G; John M; Suh KN; vanWalraven C; Vicencio E; Coulby C; Roth V; Hota S
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):24-30. PubMed ID: 27804901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
    Martínez JA; Ruthazer R; Hansjosten K; Barefoot L; Snydman DR
    Arch Intern Med; 2003 Sep; 163(16):1905-12. PubMed ID: 12963563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 10-year trends in vancomycin-resistant enterococci among allogeneic hematopoietic cell transplant recipients.
    MacAllister TJ; Stohs E; Liu C; Bryan A; Whimbey E; Phipps A; Pergam SA
    J Infect; 2018 Jul; 77(1):38-46. PubMed ID: 29746941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of vancomycin-resistant
    Cho SY; Kim HM; Chung DR; Choi JR; Lee MA; Huh HJ; Lee NY; Huh K; Kang CI; Peck KR
    Infect Control Hosp Epidemiol; 2022 May; 43(5):603-608. PubMed ID: 33993892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
    Johnstone J; Shing E; Saedi A; Adomako K; Li Y; Brown KA; Garber G
    Clin Infect Dis; 2020 Oct; 71(7):1756-1759. PubMed ID: 31922536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.
    Song JY; Cheong HJ; Jo YM; Choi WS; Noh JY; Heo JY; Kim WJ
    Am J Infect Control; 2009 Nov; 37(9):734-40. PubMed ID: 19188004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes.
    Ford CD; Gazdik MA; Lopansri BK; Webb B; Mitchell B; Coombs J; Hoda D; Petersen FB
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):340-346. PubMed ID: 27890428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
    Chuang YC; Wang JT; Lin HY; Chang SC
    BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unintended Consequences of Pretransplant Vancomycin-Resistant Enterococcus Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients.
    Stohs EJ; MacAllister T; Pergam SA; Krantz EM; Jain R; Sweet A; Liu C
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):730-733. PubMed ID: 29589825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia.
    Ye JJ; Shie SS; Cheng CW; Yang JH; Huang PY; Wu TS; Lee MH; Huang CT
    J Microbiol Immunol Infect; 2018 Dec; 51(6):705-716. PubMed ID: 29046248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition.
    D'Agata EM; Green WK; Schulman G; Li H; Tang YW; Schaffner W
    Clin Infect Dis; 2001 Jan; 32(1):23-9. PubMed ID: 11112676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
    J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible.
    Morris-Downes M; Smyth EG; Moore J; Thomas T; Fitzpatrick F; Walsh J; Caffrey V; Morris A; Foley S; Humphreys H
    J Hosp Infect; 2010 Jul; 75(3):228-33. PubMed ID: 20363048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospital acquired vancomycin resistant enterococci in surgical intensive care patients - a prospective longitudinal study.
    Kampmeier S; Kossow A; Clausen LM; Knaack D; Ertmer C; Gottschalk A; Freise H; Mellmann A
    Antimicrob Resist Infect Control; 2018; 7():103. PubMed ID: 30155243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay.
    Lloyd-Smith P; Younger J; Lloyd-Smith E; Green H; Leung V; Romney MG
    J Hosp Infect; 2013 Sep; 85(1):54-9. PubMed ID: 23920443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colonization with vancomycin-resistant enterococci (VRE) in intensive care unit patients in Cordoba City, Argentina.
    Littvik AM; López TN; González SE; Fernández CM; Pavan JV
    Rev Argent Microbiol; 2006; 38(1):28-30. PubMed ID: 16784130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
    Satlin MJ; Soave R; Racanelli AC; Shore TB; van Besien K; Jenkins SG; Walsh TJ
    Leuk Lymphoma; 2014 Dec; 55(12):2858-65. PubMed ID: 24559288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients.
    Batistão DW; Gontijo-Filho PP; Conceição N; Oliveira AG; Ribas RM
    Mem Inst Oswaldo Cruz; 2012 Feb; 107(1):57-63. PubMed ID: 22310536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.